Gα12 Structural Determinants of Hsp90 Interaction Are Necessary for Serum Response Element-mediated Transcriptional Activation
Overview
Pharmacology
Authors
Affiliations
The G12/13 class of heterotrimeric G proteins, comprising the α-subunits Gα12 and Gα13, regulates multiple aspects of cellular behavior, including proliferation and cytoskeletal rearrangements. Although guanine nucleotide exchange factors for the monomeric G protein Rho (RhoGEFs) are well characterized as effectors of this G protein class, a variety of other downstream targets has been reported. To identify Gα12 determinants that mediate specific protein interactions, we used a structural and evolutionary comparison between the G12/13, Gs, Gi, and Gq classes to identify "class-distinctive" residues in Gα12 and Gα13. Mutation of these residues in Gα12 to their deduced ancestral forms revealed a subset necessary for activation of serum response element (SRE)-mediated transcription, a G12/13-stimulated pathway implicated in cell proliferative signaling. Unexpectedly, this subset of Gα12 mutants showed impaired binding to heat-shock protein 90 (Hsp90) while retaining binding to RhoGEFs. Corresponding mutants of Gα13 exhibited robust SRE activation, suggesting a Gα12-specific mechanism, and inhibition of Hsp90 by geldanamycin or small interfering RNA-mediated lowering of Hsp90 levels resulted in greater downregulation of Gα12 than Gα13 signaling in SRE activation experiments. Furthermore, the Drosophila G12/13 homolog Concertina was unable to signal to SRE in mammalian cells, and Gα12:Concertina chimeras revealed Gα12-specific determinants of SRE activation within the switch regions and a C-terminal region. These findings identify Gα12 determinants of SRE activation, implicate Gα12:Hsp90 interaction in this signaling mechanism, and illuminate structural features that arose during evolution of Gα12 and Gα13 to allow bifurcated mechanisms of signaling to a common cell proliferative pathway.
Can Serotonin 7 Receptors Be a Treatment Target for Noncentral Diseases?.
Bilgin A Eurasian J Med. 2024; 55(1):S49-S54.
PMID: 39128036 PMC: 11075038. DOI: 10.5152/eurasianjmed.2023.23303.
Gα and Gα: Versatility in Physiology and Pathology.
Guo P, Tai Y, Wang M, Sun H, Zhang L, Wei W Front Cell Dev Biol. 2022; 10:809425.
PMID: 35237598 PMC: 8883321. DOI: 10.3389/fcell.2022.809425.
A Gα12-specific Binding Domain in AKAP-Lbc and p114RhoGEF.
Martin J, Cavagnini K, Brawley D, Berkley C, Smolski W, Garcia R J Mol Signal. 2019; 11:3.
PMID: 31051012 PMC: 5345129. DOI: 10.5334/1750-2187-11-3.
GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.
Rasheed S, Leong H, Lakshmanan M, Raju A, Dadlani D, Chong F Oncogene. 2017; 37(10):1340-1353.
PMID: 29255247 PMC: 6168473. DOI: 10.1038/s41388-017-0038-6.
Cellular mechanisms of the 5-HT7 receptor-mediated signaling.
Guseva D, Wirth A, Ponimaskin E Front Behav Neurosci. 2014; 8:306.
PMID: 25324743 PMC: 4181333. DOI: 10.3389/fnbeh.2014.00306.